| Symbol | NNVC |
|---|---|
| Name | NANOVIRICIDES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1 CONTROLS DRIVE, SHELTON, Connecticut, 06484, United States |
| Telephone | +1 203 937-6137 |
| Fax | — |
| — | |
| Website | https://www.nanoviricides.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001379006 |
| Description | Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy. Additional info from NASDAQ: |
New Form S-3 - NANOVIRICIDES, INC. <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0001104659-26-071007 <b>Size:</b> 636 KB
Read moreNew Form 424B5 - NANOVIRICIDES, INC. <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001104659-26-063050 <b>Size:</b> 563 KB
Read moreNew Form 424B3 - NANOVIRICIDES, INC. Filed: 2025-12-30 AccNo: 0001104659-25-125250 Size: 98 KB
Read moreNew Form EFFECT - NANOVIRICIDES, INC. Filed: 2025-12-19 AccNo: 9999999995-25-003874 Size: 1 KB
Read moreNew Form S-3 - NANOVIRICIDES, INC. Filed: 2025-12-15 AccNo: 0001104659-25-121169 Size: 338 KB
Read moreNew Form 424B5 - NANOVIRICIDES, INC. Filed: 2025-11-12 AccNo: 0001104659-25-110251 Size: 483 KB
Read more